Trillium Therapeutics (TRIL) PT Raised to $14 at JMP Securities
Tweet Send to a Friend
JMP Securities analyst Reni Benjamin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
